Intracranial Self-Administration in Nucleus Accumbens Shell
behavioralratNot specified
Objective: To assess the direct rewarding actions of phencyclidine (PCP) and related NMDA receptor antagonists (MK-801, CPP) by measuring lever-pressing behavior reinforced by microinjections into nucleus accumbens shell and frontal cortex
Materials & Equipment Checklist
7 items1 from ConductScience
Gather these items before starting the experiment. Check off items as you prepare.
Equipment2
Not specified • Not specified • Not specified • Not mentioned
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
View Abstract
Rats learned to lever-press when such behavior was reinforced by microinjections of phencyclidine (PCP) directly into the ventromedial (shell) region of nucleus accumbens, indicating that the drug has direct rewarding actions in that region. Separate groups of rats learned to lever-press when reinforced with microinjections of dizocilpine (MK-801) or 3-((±)2-carboxypiperazin-4yl)propyl-1-phosphate (CPP), drugs known to block NMDA receptor function but not dopamine uptake, into the same region. Each drug was ineffective or markedly less effective when injected at a slightly more dorsal and lateral site in the core of nucleus accumbens. Self-administration of PCP, MK-801, or CPP directly into nucleus accumbens was not altered by co-infusion of a dose of the dopamine antagonist sulpiride that effectively blocked intracranial self-administration of the dopamine uptake inhibitor nomifensine, suggesting that the rewarding actions of the NMDA receptor antagonists are not dopamine-dependent. Rats also developed lever-pressing habits when PCP, MK-801, and CPP were each microinjected directly into frontal cortex, a region previously associated with the rewarding actions of cocaine but not nomifensine. Thus nucleus accumbens and frontal cortex are each potential substrates for the rewarding properties of PCP and related drugs, and the ability of these drugs to disrupt NMDA receptor function seems sufficient to account for their rewarding actions. When considered with independent evidence, the present results suggest a model of drug reward within which the critical event is inhibition of medium spiny neurons in nucleus accumbens.
Protocol Steps
1
Surgical implantation of microinjection cannulae
Implant microinjection cannulae targeting the ventromedial (shell) region of nucleus accumbens in rats
Not specifiedNot specified
Note: Separate groups received implants targeting either nucleus accumbens shell or core, or frontal cortex
View evidence from paper
“Rats learned to lever-press when such behavior was reinforced by microinjections of phencyclidine (PCP) directly into the ventromedial (shell) region of nucleus accumbens”
2
Operant conditioning training - PCP group
Train rats to lever-press with reinforcement of PCP microinjections into nucleus accumbens shell
Not specifiedNot specified
Note: Rats learned lever-pressing behavior when reinforced with drug microinjections
View evidence from paper
“Rats learned to lever-press when such behavior was reinforced by microinjections of phencyclidine (PCP) directly into the ventromedial (shell) region of nucleus accumbens”
3
Operant conditioning training - MK-801 group
Train separate group of rats to lever-press with reinforcement of MK-801 microinjections into nucleus accumbens shell
Not specifiedNot specified
Note: MK-801 blocks NMDA receptor function but not dopamine uptake
View evidence from paper
“Separate groups of rats learned to lever-press when reinforced with microinjections of dizocilpine (MK-801) or 3-((±)2-carboxypiperazin-4yl)propyl-1-phosphate (CPP), drugs known to block NMDA receptor function but not dopamine uptake”
4
Operant conditioning training - CPP group
Train separate group of rats to lever-press with reinforcement of CPP microinjections into nucleus accumbens shell
Not specifiedNot specified
Note: CPP blocks NMDA receptor function but not dopamine uptake
View evidence from paper
“Separate groups of rats learned to lever-press when reinforced with microinjections of dizocilpine (MK-801) or 3-((±)2-carboxypiperazin-4yl)propyl-1-phosphate (CPP), drugs known to block NMDA receptor function but not dopamine uptake”
5
Test drug effectiveness at nucleus accumbens core
Inject each drug (PCP, MK-801, CPP) at a slightly more dorsal and lateral site in the core of nucleus accumbens to test regional specificity
Not specifiedNot specified
Note: Each drug was ineffective or markedly less effective when injected at core site compared to shell
View evidence from paper
“Each drug was ineffective or markedly less effective when injected at a slightly more dorsal and lateral site in the core of nucleus accumbens”
6
Test dopamine-dependence with sulpiride co-infusion
Co-infuse sulpiride (dopamine antagonist) with PCP, MK-801, or CPP into nucleus accumbens shell during self-administration sessions
Not specifiedNot specified
Note: Sulpiride dose was one that effectively blocked self-administration of nomifensine (dopamine uptake inhibitor)
View evidence from paper
“Self-administration of PCP, MK-801, or CPP directly into nucleus accumbens was not altered by co-infusion of a dose of the dopamine antagonist sulpiride that effectively blocked intracranial self-administration of the dopamine uptake inhibitor nomifensine”
7
Test drug effects in frontal cortex
Microinject PCP, MK-801, and CPP directly into frontal cortex and measure lever-pressing behavior
Not specifiedNot specified
Note: Frontal cortex was previously associated with rewarding actions of cocaine but not nomifensine
View evidence from paper
“Rats also developed lever-pressing habits when PCP, MK-801, and CPP were each microinjected directly into frontal cortex, a region previously associated with the rewarding actions of cocaine but not nomifensine”
Subjects / Specimens
Species
rat
Strain
Not specified
Age
Not specified
Sex
unknown
Weight
Not specified
Separate groups tested with different drugs (PCP, MK-801, CPP)